Erythrocyte aging: a more than superficial resemblance to apoptosis? by Bosman, G.J.C.G.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/47441
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
1Review
Cell Physiol Biochem 2005;16:01-08 Accepted: April 11, 2005Cellular Physiology
and Biochemistry
Copyright © 2005 S. Karger AG, Basel
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2005 S. Karger AG, Basel
1015-8987/05/0163-0001$22.00/0
Accessible online at:
www.karger.com/journals/net
Erythrocyte Aging: A More than Superficial Re-
semblance to Apoptosis?
Giel J.C.G.M. Bosman1, Frans L.A. Willekens2 and Jan M. Werre3
1Department of Biochemistry, Radboud University Nijmegen Medical Center, Nijmegen Center for
Molecular Life Sciences, 2Department of Clinical Chemistry, Rijnstate Hospital, Arnhem; 3Department of
Blood Transfusion and Transplantation Immunology, Radboud University Nijmegen Medical Center
Dr. G. Bosman, Ph.D.
Dept. Biochemistry (160), Radboud Uni Med Center Nijmegen
P.O. Box 9101, NL-6500 HB Nijmegen (The Netherlands)
Tel. +31-24-3615390/14259, Fax +31-24-3616413
E-Mail G.Bosman@ncmls.ru.nl
Key Words
Aging • Anion transporter • Apoptosis • Asplenia •
Cytoskeleton • Erythrocyte • Hemoglobin • Membrane
• Vesicles
Abstract
In physiological circumstances, erythrocyte aging
leads to binding of autologous IgG followed by
recognition and removal through phagocytosis, mainly
by Kupffer cells in the liver. This process is triggered
by the appearance of a senescent erythrocyte-
specific antigen. The functional and structural
characteristics of senescent erythrocytes strongly
suggest that this antigen originates on band 3,
probably by calcium-induced proteolysis. Generation
of vesicles enriched in denatured hemoglobin is an
integral part of the erythrocyte aging process. These
versicles are also removed by Kupffer cells, with a
major role for exposure of phosphatidylserine.
Moreover, senescent erythrocyte-specific antigens
are present on vesicles. Thus, vesicles and senescent
erythrocytes may be recognized and removed
through the same signals. These and other, recent
data support the theory that erythrocyte aging is a
form of apoptosis that is concentrated in the cell
membrane, and provide the context for future studies
on initation and regulation of the erythrocyte aging
process. Insight into the normal aging mechanism is
essential for understanding the fate of erythrocytes
in pathological circumstances and the survival of
donor erythrocytes after transfusion.
Introduction
There is no dispute that erythrocytes have a definite
lifespan in all animal species investigated so far, and there
is little dispute on the length of the species-specific
lifespans [1]. These simple statements imply that, as in
other cells, life and death are well regulated for
erythrocytes, in spite of their lack of capacity for protein
synthesis. During the last decade, a general consensus
has been established on the mechanisms by which
senescent erythrocytes are removed from the circulation.
However, the identity of the mechanisms by which
erythrocytes become senescent, i.e. by which
2erythrocytes arrive at the verge of being removed, is still
a subject of discussion. Here we will briefly review this
discussion, and introduce a new aspect, namely vesicle
formation, as an important and hitherto largely overlooked
mechanism of erythrocyte aging and removal. We will
incorporate this aspect in the established hypotheses on
erythrocyte aging, and discuss the possibility that
erythrocyte aging is a form of apoptosis.
Recognition of senescent erythrocytes
In physiological circumstances, senescent
erythrocytes are bound by autologous IgG, which leads
to recognition and phagocytosis. This represents one of
the first demonstrations of a physiological role for an
autoimmune process. In humans the responsible
phagocytes are mainly Kupffer cells in the liver, but in
other species, most notably rat and mouse, phagocytosis
may also occur in other parts of the reticulo-endothelial
system, such as the spleen [1, 2]. The IgG that is bound
to senescent erythrocytes represents one of the few
accessible clues to the identity of the antigen(s) it binds
to, and thereby to the aging mechanism itself. Therefore,
characterization of this IgG has been given a good deal
of attention (for a recent, extensive review see [3]).
However, this attention has not led to an unambiguous
view, since it has been clouded by the use of research
strategies that have depended too heavily on experiments
in vitro, in combination with plasma as a source of naturally
occurring antibodies. Plasma contains erythrocyte-specific
antibodies with various affinities, specificities and activities:
leading to complement activation or not, binding to
intracellular erythrocyte proteins such as actin and
spectrin, binding to extra- and intracellular domains of
membrane proteins such as band 3, and of low and high
affinity. The clearest view, based on analyses in which
the materials were as clean and as close to the in vivo
situation as possible, suggests that low numbers of bound
IgG (e.g. 200 molecules/erythrocyte) are sufficient for
phagocytosis, and that significant IgG binding does not
occur until during the last few weeks [4, 5]. Activation of
complement is probably not involved. When erythrocytes
of various ages were probed with antibodies against the
anti-complement proteins CD55 and CD59, the mean
fluorescence intensity decreased with erythrocyte age
(CD55, 89 ± 1.8 %; CD59 92 ± 2.8 % in the oldest relative
to the youngest erythrocytes). However, the mean surface
decreased even more, resulting in a small increase with
aging in the number of CD55 and CD59 per unit of surface
area [6]. The low number of specifically erythrocyte-
bound IgG found under physiological conditions in vivo
indicates that removal of senescent erythrocytes is an
efficient and well-orchestrated process. However, this
also implies that it is difficult to obtain enough IgG for
analysis. In those situations in which more bound
antibodies can be obtained from ‘aged’ erythrocyte
populations, it must be assumed that either the aging
mechanism and/or the removal machinery are disturbed,
and any data obtained in such circumstances must be
doubted with regard to their validity for the physiological
aging process. Various examples may illustrate this
important caveat: 1, whereas senescent erythrocyte-
specific immunoglobulins are all IgG, the immunoglobulins
present on sickled erythrocytes consist of various classes,
including IgA [7]; 2, antibodies that bind to experimentally
aged erythrocytes have a low affinity, or may represent
a blood group reaction [3, 8, 9]; 3, the amount of
autologous immunoglobulin binding after oxidation in vitro
mainly correlates with the degree of lysis, and probably
results from lysis-induced appearance of intracellular
autoantigens on the outside of intact erythrocytes
(Bosman GJCGM and Kay MMB, unpublished
observations).
CD47, also known as integrin-associated membrane
protein, mediates adhesion-related processes [10]. Recent
data have pointed towards CD47 as another molecule
that may be involved in recognition of senescent
erythrocytes by macrophages [11]. Erythrocytes from
CD47 knock-out mice, in which they have a normal
lifespan, rapidly disappeared from the circulation when
brought into wild-type recipients. So, regulation of CD47
expression might serve as a mechanism to control
elimination of senescent RBC. However, erythrocytes
from heterozygous animals survived normally in wild-type
mice, which argues against a gradual disappearance of
CD47 as the sole mechanism that regulates erythrocyte
survival. It is more likely that the absence of CD47
triggers other processes leading to erythrocyte removal,
that have not yet been identified in mice. In humans, CD47
is part of the Rhesus core complex, and Rhesusnull
individuals with less than 25% CD47 have hemolytic
anemia and stomatocytosis, but there is no evidence that
Rhnull erythrocytes are phagocytosed more readily than
erythrocytes with normal amounts of CD47 [12].
Exposure of phosphatidylserine at the outside of
erythrocytes is widely implicated as a trigger for the
removal of senescent erythrocytes (for a recent review
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3see [13]), notwithstanding the paucity of data showing
that exposure of phosphatidylserine is actually increased
during physiological aging. In fact, flow cytometry data
show the virtual absence of erythrocytes exposing
phosphatidylserine, as measured by the capacity to bind
annexin V, in all age fractions (the youngest erythrocytes,
0.31 ± 0.16 %; the oldest erythrocytes, 0.11 ± 0.06 %
positive cells [14]). The arguments for this theory are
mainly based on pathological data, and on results from
manipulation in vitro and in vivo. In erythrocyte
pathologies such as sickle cell anemia, thalassemia and
spherocytosis, a decrease in erythrocyte survival is
associated with an increase in phosphatidylserine exposure
[13]. Treatments leading to an increased calcium influx
and oxidation, that induce more or less presumed aspects
of erythrocyte aging and decreased erythrocyte survival,
also lead to inhibition of flipase and/or activation of
scramblase, both leading to loss of phospholipid
asymmetry [15]. In general, all processes that lead to
increased destruction are associated with an increased
exposure of phosphatidylserine at the erythrocyte surface.
In view of this evidence together with the general role
that phosphatidylserine plays in recognition and removal
of apoptotic cells [16], we are inclined to give
phosphatidylserine the benefit of the doubt regarding it’s
role in normal erythrocyte aging. It can not be excluded
that exposure of phosphatidylserine leads to such a fast
removal that it is underestimated [13, 14]. A decrease in
phospholipid asymmetry may very well be one of the
consequences of physiological aging at the level of the
membrane, and may result in exposure of
phosphatidylserine that, in conjunction with other signals,
partakes in the recognition and removal of senescent
erythocytes by phagocytes [16].
Thus, the accumulation of autologous, high-affinity,
and specific IgG during the final part of the erythrocyte
lifespan triggers, above a relatively low treshold, binding
and phagocytosis of senescent erythrocytes. Removal may
be promoted by the exposure of phosphatidylserine at
the erythrocyte surface.
Identity of the senescent erythrocyte-
specific antigen
Together with the consensus on the involvement of
the immune system in the recognition and removal of
senescent erythrocytes, a consensus also seems to have
been reached on the involvement of band 3 in the
generation of the senescent erythrocyte-specific antigen.
Band 3 is, at one million copies per cell, quantitatively the
major protein of the erythrocyte membrane. The C-
terminal half of the protein is an integral membrane domain
that catalyzes the electroneutral exchange of chloride and
bicarbonate. The N-terminal cytoplasmic domain
provides, through the intermediate action of ankyrin, the
interaction site by which the spectrin/actin cytoskeleton
is anchored to the lipid bilayer [17]. In addition, the
membrane domain carries the antigens of the Diego blood
group system, and the cytoplasmic domain has high-affinity
binding sites for key enzymes of the glycolysis such as
glyceraldehyde-3-phosphate dehydrogenase, aldolase and
phosphofructokinase [18]. In addition, carbonic anhydrase
II and IV may be associated with band 3 at the intra- and
extracellular side of the membrane, respectively, forming
a ‘transport metabolon’ [19, 20]. Binding of
glyceraldehyde-3-phosphate dehydrogenase to band 3
inhibits enzyme activity, suggesting that these associations,
regulated by hitherto little explored signal transduction
pathways, have a functional meaning in maintaining
erythrocyte homeostasis. This is not restricted to
metabolism and anion transport, since the linkage with
ankyrin, the assocation with glycophorin A, and the
association with the Rhesus complex through protein 4.2
all place band 3 at the center of a complex that regulates
cell shape and transport of other metabolites such as
glucose and NH3 as well [5, 21, 22]. Also, deoxy-
hemoglobin and especially denatured hemoglobin
(hemichromes) have a high affinity for the cytoplasmic
domain of band 3 [5]. There may also be a role for band
3 in release of NO during the blood flow [23].
IgG that becomes specifically bound to erythrocytes
during the final stages of their lifespan recognizes band
3, so it is obvious that changes in band 3 occurring during
the erythrocyte lifespan must precede this binding.
However, the molecular identity of the senescent
erythrocyte antigen that is recognized by this IgG, and
thus the nature of these changes, have not been
unambiguously identified. The discussion focuses on
aggregation versus breakdown of band 3 as the ultimate
steps in neoantigen formation. In the first hypothesis,
binding of denatured hemoglobin to the cytoplasmic
domains of band 3 causes oligomerization of band 3,
resulting in the formation of a neoantigen that is
recognized by senescent erythrocyte-specific IgG. This
hypothesis is supported by many data showing an
association between increased IgG binding and band 3
oligomerization in vitro and in vivo. The concomitant
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4increase in membrane-bound globin chains supports the
involvement of hemoglobin in this process [3, 4]. In the
second hypothesis, breakdown of band 3 within the
membrane domain is the central event that leads to
conformational changes resulting in the generation of a
senescent erythrocyte-specific neoantigen, senescent cell
antigen (Figure 1, [5]). This hypothesis is supported by
immunoblot data showing aging-related breakdown, and
by functional data such as an aging-related decrease in
anion transport capacity [5]. Both theories explain the
loss of interaction between membrane and cytoskeleton,
as indicated by the increased mobility of band 3, and the
decreased numbers of high-affinity binding sites for
ankyrin [4, 24]. In both scenarios there is a central role
for oxidation as a causative event, be it through
hemichrome generation in the oligomerization hypothesis
or through inducing an increased sensitivy of band 3 to
proteolysis in the breakdown hypothesis. Various data
indicate that age-related breakdown of band 3 is caused
by activation of calcium-sensitive proteases [25].
At the moment both hypotheses remain unfalsified,
probably for a number of reasons: 1, changes in the
cytoplasmic domain of band 3 affect structure and function
of the membrane domain and vice versa, which makes it
difficult to pinpoint the original site of disturbance; 2,
because of the central role of band 3 in erythrocyte
homeostasis, many processes induce changes in band 3,
including erythrocyte-specific pathology but possibly also
other conditions such as old age, pregnancy, cardiovascular
pathology, and diabetes [26-28]. In addition, the presence
of denatured hemoglobin per se, such as in unstable
hemoglobinopathies, is not clearly associated with a
accelerated erythrocyte aging phenotype [29]. This makes
it difficult to establish a chain of cause and effect; 3, in
view of the above, it is also difficult to establish the value
of artificial and pathological model systems for all possibly
relevant aspects of the physiological aging process; 4,
structural changes in especially the membrane domain of
band 3 that are present in situ may easily be lost upon
membrane isolation and further analytical procedures; 5,
obtaining erythrocyte populations of well-defined cellular
age is a laborious procedure.
The role of vesiculation during erythrocyte
aging
Using a combination of counterflow centrifugation
and subsequent density centrifugation it was possible to
determine unequivocally that during aging the erythrocyte
Fig. 1. Breakdown of band 3 within the membrane domain
leads to a change in protein conformation, and generates
senescent cell antigen [5].
Fig. 2. Plasma contains small (< 200 nm) vesicles with right-
side-out and inside-out-oriented membranes, and larger (200 –
800 nm) vesicles with predominantly right-side-out membranes
[33].
volume decreases with time, with an increase in density
especially during the first, and a decrease in hemoglobin
content especially during the second part of the lifespan
[30]. These changes are associated with a loss of
Bosman/Willekens/WerreCell Physiol Biochem 2005;16:01-08
5cholesterol and phospholipid and a linear decrease in the
mean surface area of 20 per cent, which all pointed
towards a loss of membrane during aging. This loss could
be readily explained through the formation of
microvesicles by erythrocytes of all ages (Figure 2), with
vesicles derived from older erythrocytes containing more
hemoglobin. Immunological analysis of these vesicles by
flow cytometry and immunoblotting revealed that a portion,
but not all of these vesicles contain IgG at their surface,
expose phosphatidylserine, and may contain breakdown
products of band 3 that are also found on the oldest
erythrocytes (Willekens et al, in preparation). HPLC
analysis showed that the hemoglobin composition of these
vesicles resembles that of the oldest erythrocytes, including
HbA1c and what are probably more advanced glycation
and carbamylation products [31]. Vesicles disappear
rapidly from the circulation: in a rat model, Kupffer cells
in the liver remove naturally occurring, hemoglobin-
containing, erythrocyte-derived vesicles from the
circulation within minutes, mainly by scavenger receptors
and with phosphatidylserine as the principal ligand (Figure
3, [32]). Taken together, these data represent the discovery
of a new and hitherto obscure pathway of erythrocyte
removal in which 20 per cent of the hemoglobin and the
cell membrane are involved. They also place a
considerable fraction of the premortal substrate at our
disposal. It should be noted that the spleen plays an
important, although poorly understood role in the expulsion
and possibly also the removal of vesicles. After
splenectomy, vacuoles - the presumed precursors of
vesicles - start to accumulate in erythrocytes of all ages.
In older erythrocytes absolute increases of HbA1c and
HbA1e2 are measured. Also, an increase in total
hemoglobin content and an increase in surface area
relative to those of control old cells could be demonstrated
[33, 34]. Taken together, these observations point towards
the retention of vesicles especially in erythrocytes
containing older hemoglobin. Therefore, it can be stated
that the spleen facilitates the erythrocyte vesiculation
process. It is plausible that Heinz bodies and other
inclusion bodies leave the erythrocyte the same way. It
can also be speculated that the beneficial effect of
splenectomy in some patients with hemolytic anemia
caused by inborn errors in erythrocyte membrane proteins
[35], may be caused by the prevention of inappropriate
vesiculation which, in these patients, would result in more
robust erythrocytes.
A full proteomic and immunologic comparative
analysis of the vesicles produced in physiological
circumstances in vivo and erythrocyte fractions of various
ages is on the way (Bosman et al, in preparation).
However, the available data already allow the combination
of aging-associated vesiculation with the current
hypotheses described above, into a new hypothesis on
Fig. 3. A, within 5 minutes, 51Cr-chromate-labeled vesicles are
removed from the circulation with a concomitant uptake by the
liver; B, nearly all liver activity is found in Kupffer cells, with a
concomitant uptake of hemoglobin; C, this uptake is inhibited
by preinjection of phosphatidylserine liposomes (  ), but not
phosphatidylcholine liposomes (  ) [32].
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6the erythrocyte aging mechanism. We propose that protein
modification by oxidation, glycation, carbamylation,
nitrosylation, or ubiquitinylation occurs already early in
the life of the erythrocyte. The occurrence of all these
processes in the erythrocyte has been documented, in
some cases also modifying band 3 [36]. If hemoglobin is
the main victim, this may result in the binding of denatured
hemoglobin to the cytoplasmic domain of band 3 and
subsequent breakdown within the band 3 membrane
domain. When band 3 is the main victim, this may result
in the binding of hemoglobin to band 3 breakdown products
that are already present. Activation of proteases by
calcium is likely to be involved in band 3 breakdown, with
calcium entering the erythrocyte possibly through
activation of cell volume-sensitive cation channels [37,
38]. Either theory explains the presence of band 3
breakdown products in all but the youngest fraction at
much higher concentrations than seem to be necessary
for binding of the few hundred IgG molecules that are
sufficient for phagocytosis of the senescent fraction [5].
The presence of band 3 breakdown products may also
explain the loss of water during the first part of the
lifespan as an osmotic consequence of a decrease in band
3-catalyzed anion transport capacity [5, 30]. Lateral
diffusion of the band 3 fragments, driven either by
aggregation of the associated hemichromes, or by
exclusion from the functional units consisting of band 3
di- and tetramers, may lead to their aggregation which
would increase membrane curvature and thereby induce
vesiculation [39]. Alternatively, breakdown of band 3 within
its membrane domain is likely to disturb the lipid
organization by loss of lipid anchorage, and affect the
mobility of lipids in succesive layers. It remains to be
established if this is reflected by or related to raft formation
[40, 41]. This could lead to vesicle formation where the
cytoskeleton remains intact, such as occurs in the
erythrocytes of band 3 knock-out animals [42]. Thus,
vesicles containing denatured hemoglobin also display the
signal for their removal in the form of senescent
erythrocyte-antigen on band 3 fragments. Through this
process, non-functional and/or toxic products are
continuously removed from the erythrocyte for the better
part of it’s lifespan. At the end, however, the cellular
defenses wear down and the vesicle formation system
becomes overburdened, resulting in removal of the whole
erythrocyte. Although there are similarities between the
mechanisms and receptors involved in recognition and
phagocytosis of vesicles and senescent erythrocytes, it is
not clear whether they are completely identical.
Erythrocyte aging represents the execution
phase of the apoptosis process
Cell death is considered as apoptosis when it
processes through an ordered chain of events, that are
triggered by an extra- or intracellular stress signal (the
activation phase), and when: 1, the protein components
of the cell death process are constitutively expressed; 2,
the execution phase involves a calcium-dependent
proteolytic cascade (the execution phase); 3, activation
is controlled by dedicated regulatory proteins; 4, the
remains are removed by phagocytosis, without
inflammation (burial phase). In addition, destabilization
of the connection between the cytoskeleton and the cell
membrane, resulting in blebbing and fragmentation, may
be a regulated event, and phagocytosis of cell fragments
is triggered by ‘distinguishing features’ such as the
presence of phosphatidylserine at their surface [16, 43].
A compilation of the keywords of the processes that lead
to the removal of senescent erythrocytes from the
circulation described above – aging, autoimmunity,
calcium-dependent proteolysis, vesiculation, oxidation,
phagocytosis, phosphatidylserine exposure – shows an
almost complete overlap with the terms that characterize
the apoptotic process of nucleated cells. This has already
been put forward by others [37, 38, 44], and is supported
by data suggesting the involvement of calcium, showing
oxidation and aging-related activation of caspases [45,
46], possibly mediated by membrane-associated Bcl-X(L)
[47], and leading to phosphatidylserine exposure,
breakdown of band 3 and phagocytosis [45, 48]. In this
context it should be emphasized that the data obtained
during the last decade show that the erythrocyte contains
a complex, functional set of regulatory systems. ATP
content, concentrations of anions and cations, cell volume
and cell shape are not the immutable consequences of
the erythrocyte’s surroundings but, as in all cells, are
regulated as a response to and meeting the demands of
neighbouring cells and organs [49-51]. Thus, various signal
transduction pathways are present and active, putting life
and death of the erythrocyte once more at a central position
in the study of organismal homeostasis.
The current knowledge of the erythrocyte aging
process reviewed here, together with the view of the
erythrocyte as a specialized cell with it’s own homeostasis
and signal transduction machinery, lead inevitably to the
thesis that the processes leading to removal of
erythrocytes from the circulation are those of the
execution phase of a apoptosis program. This conclusion
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